News & Info


Page 18 of 31« First...10...1617181920...30...Last »

September 5, 2013

Eylea Approved in Europe for CRVO

Posted in: Latest News

Regeneron Pharmaceuticals’ Eylea (aflibercept) treatment for central retinal vein occlusion (CRVO) has been approved by the European Commission. Eylea was approved in the United States for the treatment of neovascular (wet) age-related macular degeneration (AMD) in 2011, and for macular edema following CRVO in 2012. The drug has also been approved in Europe, Japan, Australia,
read more »

September 2, 2013

What Is Low Vision Rehabilitation?

Posted in: Low Vision Rehabilitation

Low vision rehabilitation is like physical therapy for someone who has lost a limb. Its purpose is to develop strategies to maximize or substitute for diminished sight in order to maintain independence and a sense of self-worth. This rebuilding and reinforcement of the visual foundation is accomplished through identification of goals, introduction to assistive devices,
read more »

September 2, 2013

Statin Therapy Lowers Risk of Cataracts

Posted in: Latest News, Research and Developments

by Dan Roberts Statin therapy has been shown to reduce inflammation in the retina, but there has been some concern about cataract development for those who use the drugs. In a press conference at the European Society of Cardiology meeting, Aug 30, 2013, John B. Kostis, MD (UMDNJ-Robert Wood Johnson Medical School, New Brunswick, N.J.)
read more »

August 29, 2013

“As-Needed” Injections Are an Option for Wet AMD

Posted in: Latest News, Research and Developments, Therapies, Treatments, and Procedures

Two-year results from the recently-completed HARBOR trial showed that some patients with wet AMD fare as well from Lucentis (ranibizumab) injections on an as-needed basis compared to a monthly basis. The original Lucentis trial recommended monthly dosing until the eye stabilized. The follow-up study, however, found that 93% of patients responded well with an average
read more »

August 27, 2013

Lampalizumab Effective in Slowing Progression of Dry AMD

Posted in: Latest News, Research and Developments

Roche Pharmaceutical has announced positive phase II results from their MAHALO phase II study of lampalizumab (aka anti-factor D). The study showed a 20.4 percent reduction in progression of advanced dry macular degeneration (geographic atrophy) at 18 months. Lampalizumab is designed to inhibit Complement Factor D, a protein that is part of the alternative complement
read more »

August 22, 2013

Support Groups Can Improve Quality of Life

Posted in: Daily Living, Latest News, Research and Developments

by Dan Roberts Researchers have found that facilitated patient support groups can significantly improve visual quality of life (VQoL) for visually impaired people. Twenty-nine groups of up to six patients each were recruited for participation in a “peer group emotional support service” facilitated by trained counselors for a period of six months. Their responses to
read more »

August 21, 2013

Improving Autophagy Function Reduces Drusen

Posted in: Latest News, Research and Developments

by Dan Roberts Researchers at the University of Eastern Finland have discovered that a cleaning mechanism in the center of the retina may be faulty in people who develop age-related macular degeneration (AMD). A cleaning process called autophagy helps clear cellular waste deposits (drusen) that can build up in the retinal tissue. If autophagy diminishes,
read more »

August 19, 2013

Doctors Don’t Like Talking to Patients

Posted in: Daily Living

An editorial by Frank J. Weinstock, M.D., F.A.C.S. Reprinted with permission from Opthalmology Management (May 1999)      If you’re frustrated by your doctor’s lack of social skills, you’re not alone. It’s a problem common enough that doctors themselves sometimes have to remind one another of the importance of good communication with their patients. Here is an editorial
read more »

August 19, 2013

Medicare Approves Payment for Argus® II Retinal Prosthesis System

Posted in: Latest News, Therapies, Treatments, and Procedures

Payments Will Facilitate Beneficiary Access to Argus II in both Inpatient and Outpatient Settings  Sylmar, CA- August 15, 2013—Second Sight Medical Products, Inc. today announced that The Argus® II Retinal Prosthesis System (Argus II) has been approved by the Centers for Medicare and Medicaid Services (CMS) beginning October 1, 2013.  These payments are designed to support
read more »

August 15, 2013

Study of aquaporins could hold clues to cataract

Posted in: Latest News, Research and Developments

Researchers have achieved dynamic, atomic-scale views of a protein needed to maintain the transparency of the lens in the human eye. The work, funded in part by the National Institutes of Health, could lead to new insights and drugs for treating cataract and a variety of other health conditions. Aquaporin proteins form water channels between
read more »

August 13, 2013

Recognizing Cataract

Posted in: Eye Conditions, Latest News

Watch for Vision Changes as You Age As life goes on, we all start to notice certain changes that are a natural part of aging. Maybe our joints aren’t as flexible as before, or our hearing just isn’t what it used to be. Our vision, too, may be less sharp than it once was. One
read more »

July 23, 2013

Disparities in Eye Care Could Cost Some Their Sight

Posted in: Latest News, Research and Developments

Low-income, less educated don’t have same access to preventive treatments, researchers report By Robert Preidt THURSDAY, July 18 (HealthDay News) — Americans with low incomes and education levels are less likely to get eye care, a new study finds. Researchers examined data from nearly 3,600 people, aged 40 and older, who took part in the
read more »

July 20, 2013

Gene Therapy Without Retinal Risk

Posted in: Latest News, Research and Developments, Therapies, Treatments, and Procedures

Researchers have developed a method of delivering genes to the inner layers of the retina without the risks associated with injection into the delicate tissues themselves. This less invasive technique has been carried out successfully in animal models by a research team led by Drs. John G. Flannery and David V. Schaffer at the University
read more »

July 19, 2013

Gene Expression in the Retina Expanded

Posted in: Latest News, Research and Developments

Identifying the genetics of retinal degeneration has become especially important with progress of trials in gene therapy. Investigators have identified more than 200 retinal degeneration disease genes, but still haven’t been able to find the cause of disease in up to half of cases. Now Ocular Genomics Institute has announced that Drs. Michael Farkas, Eric
read more »

July 17, 2013

Fish Oil and Prostate Cancer? Be Suspect

Posted in: Health and Nutrition, Latest News

by Ellen Troyer, MT MA Biosyntrx CEO / Chief Research Officer Voting Member, Council for Responsible Nutrition A number of alarmist are suggesting that Omega-3 fatty acid intake increases prostate cancer risks, based on questionable follow-up conclusions of a 2011 prospective study published in The Journal of the National Cancer Institute. Here is a quick
read more »

Page 18 of 31« First...10...1617181920...30...Last »

Custom Wordpress design and web development by Jeff Roberts Web Design

WP-Backgrounds by InoPlugs Web Design and Juwelier Schönmann